Ledger.Open graph →
SEC Form D · filed August 26, 2015

VBI VACCINES INC

Offering
$6.3M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Steve T. Gillis · Cambridge, MADirectorDavid E. Anderson · Cambridge, MAExecMichel T. De Wilde · Cambridge, MADirectorJeff Baxter · Cambridge, MAExec · DirectorTrent T. Davis · Cambridge, MADirectorMichael T. Steinmetz · Cambridge, MADirectorSam T. Chawla · Cambridge, MADirectorAlan T. Timmins · Cambridge, MADirectorSteven W. Reints · Baton Rouge, LADirectorStephen K. Bowen · Baton Rouge, LADirectorJeffrey B. Bartlam · Baton Rouge, LAExecAddison Clark Capital, L.L.C · Stamford, CTExec · DirectorMarc T. Kirchmeier · Cambridge, MAExecEgidio Nascimento · Cambridge, MAExecAlan T. Timmins · Cambridge, MADirectorAdam T. Buckley · Cambridge, MAExecJames C. Crain · New York, NYExecAkeida Partners, LLC · New York, NYDirectorAkeida Capital Management, LLC · New York, NYDirectorBrandon M. Shelton · Fort Mill, SCExec · DirectorMarc T. Kirchmeier · Cambridge, MAExecEgidio Nascimento · Cambridge, MAExecTrent T. Davis · Cambridge, MADirectorMichael T. Steinmetz · Cambridge, MADirectorSam T. Chawla · Cambridge, MADirectorAdam T. Buckley · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗